CCR1 and breast carcinoma: Silencing of AKT1 in T24 bladder carcinoma cells and Capan-1 pancreatic carcinoma cells yielded similar results, suggesting that CCR1 expression activation via the AKT-STAT3 pathway is not restricted to breast cancer cells.